Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012 Jul;60(4):255-61.
doi: 10.4103/0301-4738.98700.

Glaucomatous neurodegeneration: an eye on tumor necrosis factor-alpha

Affiliations
Review

Glaucomatous neurodegeneration: an eye on tumor necrosis factor-alpha

Renu Agarwal et al. Indian J Ophthalmol. 2012 Jul.

Abstract

Glaucoma, a neurodegenerative disease, is currently being treated by modulation of one of its primary risk factors, the elevated intraocular pressure. Newer therapies that can provide direct neuroprotection to retinal ganglion cells are being extensively investigated. Tumor necrosis factor-α, a cytokine, has been recognized to play an important role in pro and antiapoptotic cellular events. In this paper we review the relevant literature to understand (1) The association of increased expression of tumor necrosis factor-α with glaucomatous neurodegeneraion, (2) Modulation of tumor necrosis factor-α expression by exposure to various risk factors of glaucoma, (3) Downstream cellular signaling mechanisms following interaction of tumor necrosis factor-α with its receptors and (4) Role of tumor necrosis factor-α as a possible target for therapeutic intervention in glaucoma. Literature was reviewed using PubMed search engine with relevant key words and a total of 82 English language papers published from 1990 to 2010 are included in this review.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None declared.

Figures

Figure 1
Figure 1
Role of TNF-A in retinal ganglion cell apoptosis induced by elevated intraocular pressure and retinal ischemia
Figure 2
Figure 2
Molecular mechanisms in TNF-induced prosurvival and apoptotic signaling

References

    1. Quigley HA. Number of people with glaucoma worldwide. Br J Ophthalmol. 1996;80:389–93. - PMC - PubMed
    1. Resnikoff S, Pascolini D, Etya’ale D, Kocur I, Pararajasegaram R, Pokharel GP, et al. Global data on visual impairment in the year 2002. Bull World Health Organ. 2004;82:844–51. - PMC - PubMed
    1. Weinreb RN, Khaw PT. Primary open-angle glaucoma. Lancet. 2004;363:1711–20. - PubMed
    1. Aggarwal BB. Signaling pathways of the TNF superfamily: A double-edged sword. Nat Rev Immunol. 2003;3:745–56. - PubMed
    1. Tracey K, Cerami A. Metabolic Response to Cachectin/TNF. In: Boland B, Cullinan J, Kimball C, editors. Annals of the New York Academy of Sciences. New York: New York Academy of Sciences; 1990. pp. 325–30. - PubMed

MeSH terms

Substances